4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow EDP-305: new trials by email Literature Review of EDP-305 trials Research Report on EDP-305
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects EDP-305, Oral Contraceptive - NASH - Nonalcoholic Steatohepatitis | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 43 | 2018-11-27 | 2019-07-24 |
| Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects EDP-305 - NASH - Nonalcoholic Steatohepatitis | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 8 | 2018-10-05 | 2018-11-21 |
| Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers Fluconazole, Quinidine, EDP-305 - NASH - Nonalcoholic Steatohepatitis | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2018-07-19 | 2018-12-05 |
| Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. Midazolam, Caffeine, Rosuvastatin - NASH | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 24 | 2017-05-11 | 2017-08-21 |
Non-alcoholic Fatty Liver Disease (3)
Enanta Pharmaceuticals, Inc (4)
United States (4)